To evaluate the benefits and harms of interferon in people with lamivudine-resistant chronic hepatitis B virus infection.
This is a protocol.
To evaluate the benefits and harms of interferon in people with lamivudine-resistant chronic hepatitis B virus infection.
This is a protocol.